Maynard Um
-
-
-
-
-
-
-
InMed Pharmaceuticals reduces exercise price on preferred investment options
-
-
-
-
-
-
-
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
-
-
-
-
-
-
-
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
-
-
-
-
-
-
-
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals (INM) Announces INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
-
-
-
-
-
-
-
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Files for 3M Share Offering by Selling Stockholders
-
420,507 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

